drugset / Trial / NCT06742606

Efficacy of Biological Therapy in Pediatric Inflammatory Bowel Disease

NCT06742606

Phase 0 Not yet recruiting 40 enrolled Ain Shams University
NaSingle-groupOpen-labelTreatment

Summary

Compare efficacy of different biologicals in induction of remission including clinical, laboratory and histopathological remission.

Timeline

Start
2025-01-15
Primary completion
2026-04-13
Completion
2026-12-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Adalimumab Monoclonal antibody
Subject Ustekinumab Monoclonal antibody

Indications

No indication recorded.